Fascinating paper. Relatively low numbers for test subjects so I question some of the statistics. I genuinely look forward to trying Bald's eyesalve for its designed purpose in animals. I came up against a muti-drug resistant Pseudomonas that was only sensitive to Amikacin recently. I did not relish the idea of treating this dogs severe infectious blepharitis and secondary stromal corneal ulceration with a systemic drug that is both hard on the kidneys and painful to receive via daily injections.
Fascinating paper. Relatively low numbers for test subjects so I question some of the statistics. I genuinely look forward to trying Bald's eyesalve for its designed purpose in animals. I came up against a muti-drug resistant Pseudomonas that was only sensitive to Amikacin recently. I did not relish the idea of treating this dogs severe infectious blepharitis and secondary stromal corneal ulceration with a systemic drug that is both hard on the kidneys and painful to receive via daily injections.